(15056629), L. M. G., (15056632), R. O., (15056635), A. S., (15056638), M. M. T., (15056641), M. S., (15056644), D. C., . . . (15051360), K. G. (2025). Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.
Dyfyniad Arddull Chicago(15056629), Lindsay M. Gurska, et al. Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. 2025.
Dyfyniad MLA(15056629), Lindsay M. Gurska, et al. Supplementary Table 1 from Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms. 2025.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.